Literature DB >> 8262367

Presumptive identification of common adenovirus serotypes by the development of differential cytopathic effects in the human lung carcinoma (A549) cell culture.

S M Lipson1, I A Poshni, R L Ashley, L J Grady, Z Ciamician, S Teichberg.   

Abstract

The neutralization test is commonly used in clinical virology laboratories for the identification by serotype of adenovirus isolates. In an effort to conserve reagents and reduce the amount of time in the performance of this assay, we evaluated the significance of differential cytopathic effects for the presumptive identification of lower-numbered adenovirus serotypes that are commonly encountered in the clinical setting. Utilizing the human lung carcinoma (A549) cell culture as our indicator system, two viral induced monolayer degenerations (i.e., cytopathic effects or CPEs) were recognized. Among our wild and the laboratory adapted (i.e., ATCC) adenovirus isolates tested in this study, serotypes 1, 2, 4, 5, 6, 8, 11, 19, 21, 27, and 31 were expectedly characterized by the typically enlarged, rounded, and refractile cells, which eventually aggregated into irregular 'grape-like' clusters. Adenovirus types 3 and 7, however, were characterized by the development of distinct intranuclear inclusions, a flattening and then a web or net-like monolayer degeneration. Differences in the intensity of intranuclear granulation were related by electron microscopy to differences in the quantity of viral crystalline aggregates within the host cell nucleus. A presumptive identification of the commonly encountered adenovirus serotypes 3 and 7 prior to the performance of the neutralization test would result in a conservation of type-specific antiserum, a decreased use of cell cultures and medium, and lastly, reduced medical technologist workload.

Entities:  

Mesh:

Year:  1993        PMID: 8262367     DOI: 10.1111/j.1574-6968.1993.tb06510.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  8 in total

1.  Detection of Enteroviruses in Water Samples from Yopougon, Côte d'Ivoire by Cell Culture and Polymerase Chain Reaction.

Authors:  K J Momou; C Akoua-Koffi; M Dosso
Journal:  Food Environ Virol       Date:  2013-11-02       Impact factor: 2.778

2.  A novel hybrid adenoretroviral vector with more extensive E3 deletion extends transgene expression in submandibular glands.

Authors:  Changyu Zheng; Ana P Cotrim; Nikolay Nikolov; Fumi Mineshiba; William Swaim; Bruce J Baum
Journal:  Hum Gene Ther Methods       Date:  2012-07-20       Impact factor: 2.396

3.  Cellular Zinc Finger Protein 622 Hinders Human Adenovirus Lytic Growth and Limits Binding of the Viral pVII Protein to Virus DNA.

Authors:  Kwangchol Mun; Tanel Punga
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

Review 4.  Adenoviruses in immunocompromised hosts.

Authors:  Marcela Echavarría
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

5.  Rescue and production of vaccine and therapeutic adenovirus vectors expressing inhibitory transgenes.

Authors:  Jason G D Gall; Alena Lizonova; Damodar EttyReddy; Duncan McVey; Mohammed Zuber; Imre Kovesdi; Barbara Aughtman; C Richter King; Douglas E Brough
Journal:  Mol Biotechnol       Date:  2007-03       Impact factor: 2.695

6.  Antiviral effects on bacteriophages and rotavirus by cranberry juice.

Authors:  S M Lipson; L Sethi; P Cohen; R E Gordon; I P Tan; A Burdowski; G Stotzky
Journal:  Phytomedicine       Date:  2006-11-29       Impact factor: 5.340

7.  A novel adenovirus species associated with an acute respiratory outbreak in a baboon colony and evidence of coincident human infection.

Authors:  Charles Y Chiu; Shigeo Yagi; Xiaoyan Lu; Guixia Yu; Eunice C Chen; Maria Liu; Edward J Dick; Kenneth D Carey; Dean D Erdman; Michelle M Leland; Jean L Patterson
Journal:  mBio       Date:  2013-04-16       Impact factor: 7.867

8.  A cost effective real-time PCR for the detection of adenovirus from viral swabs.

Authors:  Turkiya Al-Siyabi; Khalifa Binkhamis; Melanie Wilcox; Sallene Wong; Kanti Pabbaraju; Raymond Tellier; Todd F Hatchette; Jason J LeBlanc
Journal:  Virol J       Date:  2013-06-07       Impact factor: 4.099

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.